Revolution Medicines News

S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

05:17

8-K: Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress

04:10

DEFA14A: Others

Apr 26 04:41

DEF 14A: Definitive information statements

Apr 26 04:38

Revolution Medicines | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Mar 5 06:27

Revolution Medicines | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 06:07

Revolution Medicines | 8-K: Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress

Feb 27 05:09

Revolution Medicines | 8-K: Current report

Jan 9 13:00

Revolution Medicines | 8-K/A: Current report (Amendment)

Dec 26, 2023 13:00

Revolution Medicines | 8-K: Current report

Nov 9, 2023 22:20

Revolution Medicines | 8-K: Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress

Nov 7, 2023 05:05

Revolution Medicines | DEFA14A: Others

Nov 1, 2023 19:15

Revolution Medicines | 8-K: Current report

Nov 1, 2023 19:08

Revolution Medicines | 8-K: Current report

Oct 23, 2023 18:11

Revolution Medicines | 8-K: Current report

Oct 13, 2023 23:54

Revolution Medicines | DEFM14A: Definitive proxy statement relating to merger or acquisition

Sep 30, 2023 04:19

Revolution Medicines | 8-K: Current report

Sep 6, 2023 04:02

Revolution Medicines | 8-K: Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress

Aug 9, 2023 04:04

Revolution Medicines | 8-K: Current report

Aug 1, 2023 19:10

Revolution Medicines | 8-K: Current report

Jun 10, 2023 04:07